易方达全球医药行业混合发起式(QDII)C(美元现汇)(019036)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
486.69 |
948.87 |
32,442,278.49 |
- |
| 存出保证金 |
9.04 |
120,574.97 |
196,716.68 |
4,021.32 |
| 交易性金融资产 |
1,201,879,912.35 |
1,501,702,621.88 |
1,203,271,230.26 |
879,731,665.55 |
| 其中:股票投资 |
1,162,848,638.34 |
1,501,702,621.88 |
1,203,271,230.26 |
879,731,665.55 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
504,182.97 |
2,907,918.50 |
- |
7,687,764.17 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
787,000.90 |
183,481.34 |
2,530,473.12 |
- |
| 应收申购款 |
11,723,810.42 |
23,560,241.09 |
21,420,816.32 |
2,646,254.60 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,327,087,830.41 |
1,665,394,778.56 |
1,347,038,990.84 |
946,205,324.96 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
3,954,738.72 |
253.72 |
22,578,125.85 |
3,727,680.11 |
| 应付赎回款 |
28,242,586.84 |
40,317,633.26 |
35,881,905.12 |
2,462,652.67 |
| 应付管理人报酬 |
1,259,242.82 |
1,748,702.25 |
1,208,371.39 |
998,105.38 |
| 应付托管费 |
209,873.79 |
291,450.37 |
201,395.22 |
166,350.88 |
| 应付销售服务费 |
184,309.54 |
263,397.55 |
64,244.57 |
47,932.42 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
193,050.24 |
428,295.17 |
490,342.14 |
402,398.88 |
| 负债合计 |
34,043,801.95 |
43,049,732.32 |
60,424,384.29 |
7,805,120.34 |
| 所有者权益 |
| 实收基金 |
1,144,171,482.46 |
1,319,456,153.80 |
1,165,809,998.85 |
1,304,455,293.39 |
| 未分配利润 |
148,872,546.00 |
302,888,892.44 |
120,804,607.70 |
-366,055,088.77 |
| 所有者权益合计 |
1,293,044,028.46 |
1,622,345,046.24 |
1,286,614,606.55 |
938,400,204.62 |
| 负债及所有者权益总计 |
1,327,087,830.41 |
1,665,394,778.56 |
1,347,038,990.84 |
946,205,324.96 |